rs781627051
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_ModeratePP5_Moderate
The NM_001010867.4(IBA57):āc.323A>Cā(p.Tyr108Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000394 in 1,521,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y108C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001010867.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IBA57 | NM_001010867.4 | c.323A>C | p.Tyr108Ser | missense_variant | 1/3 | ENST00000366711.4 | NP_001010867.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IBA57 | ENST00000366711.4 | c.323A>C | p.Tyr108Ser | missense_variant | 1/3 | 2 | NM_001010867.4 | ENSP00000355672.3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152024Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.00000365 AC: 5AN: 1369762Hom.: 0 Cov.: 33 AF XY: 0.00000444 AC XY: 3AN XY: 676094
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152024Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74254
ClinVar
Submissions by phenotype
Multiple mitochondrial dysfunctions syndrome 3 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 16, 2019 | The p.Tyr108Ser variant in IBA57 has been reported in 2 individuals with Multiple mitochondrial dysfunctions syndrome 3, including progressive cavitating leukoencephalopathy, who were compound heterozygous for loss of function variants in the IBA57 and segregated with disease in 1 affected individual (Ishiyama 2017). It was absent from large population studies. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In vitro functional studies provide some evidence that this variant impacts protein function (Ishiyama 2017); however, these types of assays may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive Multiple mitochondrial dysfunctions syndrome 3. ACMG/AMP Criteria applied: PM3_Strong, PM2, PP1, PS3_Supporting. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 25, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at